European regulators says Lilly Alzheimer’s drug shouldn’t get marketing approval

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

oenblsoirlrUjet.EeEdnraiegapdpyn laoen t cvolipag esyoneu mleirdoenaetuAtl lseS dm skiet s eeemo yirlerin..nrfiAivsi-r wzelt’atLec darrdg egao sa’tpr mbt ehslu

rd rgesenciwiunasbgdrst hsrgon,feutEk, m.drcc i e e hsn osfiorneMeinuee K k zpna m w ieAntmtdiee rtsitddn iThiog ayefoinhadfle iurnhe,ginetta e odeto utatmaucmit o oehit

e-ae dcsfy. ai rfioans pHsoeltm ro’ aaTdstnegflk miUacyixentMeniaearsommuornr s toiln ofihninacodo ieu ciP LC t

rhs hrc.aiesayd aeuis oehc mlannangKgy tdtgT drtatge entrlhr san nitohhba n mnpusihieieatt iwotugesna evaptnuaat pmsiraom ooitodhtd bnaed rkesei kiprxsr.,ahnuuoei yoli hnhdJtLdeeI a de-l cnaCrpahilona as ot aFin dy u

up temo l ahAr hrrft pi’psEi.nniCge cucaidanBiatdse freanolpnln e mE lr uto zc,7liitmace eio oooee ens

.yllgEaltiafeldKaaUaroscaa,enodvrncau sa . tsJ erd pr se - fsrblausioybmLnuaadea ralSa,bd l irkpmeea tymite etag pr eimmmf yqrehnipsir asiure e r rdcmogde.s stJ lraa, srdietyide eeeffbvheo Tu oaamag i tonh op.u

ecieositihepe,atsh flTarrtd s vh uo t datbme.an rttinn oe ldrogsns umismg aeyt foact ettn ai ntiothwniuoe

tntirmn eee ooud tlmeeoEmtacit eecm hs rr o qTotmcicaoetse slie o L mreetds lsrrmafnu unueeealiszv.ruit.age Bscoerm sd dohh iowstistto n p nhtsamkaa ee vetsearhaibaeiudnifn htoot

umtieolsn d V eidb rdhoitangn ype hts,dtyans eu ureBwbsbmebylntho n re te ao Qoede,iteiyg t awhlmnteitie’iL p ehtor nt lnmui.nutsqdk. eahhhurod h i tfr aiqardsiIoa ttlya-aioieahbgs pzo tsaAtb rico—mt siboerabraeueiblonaae ghditnduroagmtlnsnciluKectm

$3h doCSsnnm2h iamyt e mr a.trl e .y2.cnhnr9aooi8f gdorF,9dla,Lli l Eeicie$ob a

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL
TAKE 50% OFF

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

GET DEAL

Already a paid subscriber? Log In

GET DEAL

CYBER WEEK SPECIAL

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

Already a paid subscriber? Log In

CYBER WEEK SPECIAL
TAKE 50% OFF

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

GET DEAL

Already a paid subscriber? Log In

GET DEAL

CYBER WEEK SPECIAL

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

Already a paid subscriber? Log In